Although quality of life has significantly improved for patients with HIV, there are several factors influencing how we provide care and treat patients now and in the future.
This medication is associated with a number of adverse effects, such as gastrointestinal upset and peripheral neuropathies, that may be mitigated by less frequent dosing.
Individualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.
John Ostrominski, MD shares insights into the safety and efficacy of finerenone, based on data from the FINEARTS-HF trial.
An overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.
A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.
More drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.
Incorporating AI into pharmacy education is crucial to training on its appropriate use.
Holistic and compassionate counseling by a pharmacist and pharmacy-interns on-duty over weekends could positively impact patient lives, especially for older adults and economically disadvantaged patients.
The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.
Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.
Working for the USPHS offers unique compensation and quality-of-life benefits.
A panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.
By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Pharmacists are integral to setting patient expectations, monitoring liver health, and ensuring adherence to long-term follow-up for optimal outcomes with etranacogene dezaparvovec.
In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.
Gender-affirming care and inclusive practices are essential for health equity.
These facilities provide significant value to payers and patients.
Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.
Advances, challenges, and promising innovations emerge.
This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.
Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.
Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
This interstate agreement can empower pharmacists to respond to large-scale emergencies
CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.
Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.